Recordati Updates on Share Buyback Program Execution

The latest update is out from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ).

Recordati S.p.A. has updated its shareholders on the progress of its share buyback program, which was initiated to support stock options and performance share plans for its management. Between June 9 and June 13, 2025, Recordati purchased 82,346 of its own shares, representing 1.620% of its share capital, as part of its strategy to enhance shareholder value and incentivize management.

The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group with Italian roots, offering therapeutic options in specialty and general medicine drugs, as well as rare diseases. The company is listed on the Italian Stock Exchange and operates in about 150 countries across the EMEA, Americas, and APAC regions, employing over 4,580 people.

Average Trading Volume: 378,080

Technical Sentiment Signal: Strong Buy

Current Market Cap: €11.29B

See more data about REC stock on TipRanks’ Stock Analysis page.